2CELERMAJER D S,SORENSEN K F,GOOCH V M,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340:1111-1115.
3LAUFS V,LAFATA V L,PLUTZKY J,et al.Up-regulation of endothelial nitrieoxide synthase by HMG-CoA reductase inhibitors[J].Circulation,1998,97:1129-1135.
4CORSINI A,RAITERI M,SOMA M R,et al.Pathogenesis of atherosclerosis and the role of drug intervention:focus on HMG-CoA reductase inhibitors[J].Am J Cardiol,1995,76:21-28.
5BOCAN T M A,MAZUR M J,MUELLER S B,et al.Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme.A reductase in cholesterol-fed rabbits:a biochemical and morphological evaluation[J].Atherosclerosis,1994,111:127-142.
6WILLIAM J K,SUKHOVA G K,HERRINGTON D M,et al.Pravastatin has cholesterol lowering independent effects on the artery wall of atherosclerotic monkeys[J].J Am Coll Cardiol,1998,31:684-691.
7SHIOMI M,ITO T,TSUKADA T,et al.Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plagues:effect of pravastatin sodium on atherosclerosis in mature WHHI.rabbits[J].Artreioscler Thromb Vasc Biol,1995,15:1938-1944.
9PRA T T RE,DZAU V J.Pharmacological strategies to prevent restenosis:lessons learned from blockade of the renin-angiotensin system[J].Circulation,1996,96(1):148-153.
10VAU GHAN DE,ROUL EAU JL,RIDKER PM,et al.Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction[J].Circulation,1997,96(2):442-447.
